This year s distinguished faculty of legal and industry experts from Canada and the U.S. will provide you with current, in-depth information on the latest legal developments and regulatory changes in pharmaceutical and biotechnology patents. Session highlights include:
Case law on selection patents sound prediction: what is required?
File histories: alive and well in PM(NOC) litigation?
Canada s pharmaceutical price review regime and trends
Settling pharma patent cases: when to, how to and obstacles to
Improving access to medicines with a pharmaceutical patent pool: legal/business and antitrust considerations
South of the border: the year in review
Strategies in pharma patent litigation
Ground breaking decisions: how the landscape has changed for 2010
Canadian duty of good faith vs. the U.S.: where the law is headed
Past Events
9th Edition DRUG PATENTS IN CANADA 2010 - 06-07 May 2010, St. Andrew’s Club and Conference Centre, Toronto, Canada (3350)
Edition DRUG PATENTS IN CANADA 2026
Important
Please, check "Edition DRUG PATENTS IN CANADA" official website for possible changes, before making any traveling arrangements
